Iobenguane I-123 clinical trials
How each study uses iobenguane I-123 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2005 (3)
| Year | Studies |
|---|---|
| 2005 | 3 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 4
GE Healthcare (5) · University of Maryland, Baltimore (1) · Timothy M. Bateman (1) · Mayo Clinic (1) · Vancouver Coastal Health (1)
Related medicines
As reviewed, each with the page that says it.
- One of Radiopharmaceuticals source
Studies
Open first, then newest update. How each study uses iobenguane I-123 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 9
- Imaging With a Radio Tracer to Guide VT AblationsCompletedNot applicableUniversity of Maryland, BaltimoreNCT01250912Written as 123I-metaiodobenzylguanidineHow we know
- Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or NeuroblastomaCompletedPhase 3GE HealthcareNCT00126412Written as 123I-mIBG (meta-iodobenzylguanidine)How we know
- International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical DeviceTerminatedPhase 3GE HealthcareNCT02656329Written as Iobenguane I -123 InjectionHow we know
- Meta-Iodobenzylguanidine (123I-mIBG) Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular DiseaseCompletedPhase 3GE HealthcareNCT00126438Written as 123I-mIBG (meta-iodobenzylguanidine)How we know
- 123-I mIBG (AdreView) Heart-to-Mediastinal (H/M) Ratio and SPECT Imaging on a Small Field of View-High Efficiency Cardiac SPECT SystemCompletedPhase 4Timothy M. BatemanNCT01868841Written as AdreViewHow we know
- Cardiac Resynchronization and Iodine Meta-Iodobenzylguanidine (MIBG) ImagingTerminatedPhase 1Mayo ClinicNCT01522378Written as 123 iodine metaiodobenzylguanidineHow we know
- Meta-Iodobenzylguanidine Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular DiseaseCompletedPhase 3GE HealthcareNCT00126425Written as 123I-mIBG (meta-iodobenzylguanidine)How we know
- Open-label, Test-retest Study Assessing Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView.CompletedPhase 4GE HealthcareNCT01936649Written as AdreView (Iobenguane I 123 Injection)How we know
- 123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine TumorsStatus unknownPhase 3Vancouver Coastal HealthNCT01373736Written as 123I-meta-iodobenzylguanidineHow we know
Given beside what is tested · 1 — iobenguane I-123 is usual care or a partner of the new treatment
Codes
What other systems call iobenguane I-123 · ClinicalTrials.gg INT017529
- UNII (FDA) P2TH1XYZ84IOBENGUANE I-123Confirmed FDA, Wikidata
- RxNorm 1426748Confirmed FDA, Wikidata
- Wikidata Q27286037iobenguane I-123Confirmed FDA, Wikidata
- NCI Thesaurus C80094Iobenguane I-123One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | P2TH1XYZ84 | IOBENGUANE I-123 | Confirmed FDA, Wikidata |
| RxNorm | 1426748 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27286037 | iobenguane I-123 | Confirmed FDA, Wikidata |
| NCI Thesaurus | C80094 | Iobenguane I-123 | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.